DK1365737T3 - Stabile salte af o-acetylsalicylsyre med basiske aminosyrer - Google Patents

Stabile salte af o-acetylsalicylsyre med basiske aminosyrer

Info

Publication number
DK1365737T3
DK1365737T3 DK01956511T DK01956511T DK1365737T3 DK 1365737 T3 DK1365737 T3 DK 1365737T3 DK 01956511 T DK01956511 T DK 01956511T DK 01956511 T DK01956511 T DK 01956511T DK 1365737 T3 DK1365737 T3 DK 1365737T3
Authority
DK
Denmark
Prior art keywords
amino acids
basic amino
acetylsalicylic acid
stable salts
salts
Prior art date
Application number
DK01956511T
Other languages
Danish (da)
English (en)
Inventor
Gerhard Franckowiak
Hubert Appolt
Gregor Leifker
Hans-Peter Wirges
Wolfram Ledwoch
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of DK1365737T3 publication Critical patent/DK1365737T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
DK01956511T 2000-07-18 2001-07-05 Stabile salte af o-acetylsalicylsyre med basiske aminosyrer DK1365737T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10034802A DE10034802A1 (de) 2000-07-18 2000-07-18 Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
PCT/EP2001/007669 WO2002005782A2 (fr) 2000-07-18 2001-07-05 Sels stables d'acide o-acetylsalicylique avec des acides amines basiques

Publications (1)

Publication Number Publication Date
DK1365737T3 true DK1365737T3 (da) 2005-07-11

Family

ID=7649258

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01956511T DK1365737T3 (da) 2000-07-18 2001-07-05 Stabile salte af o-acetylsalicylsyre med basiske aminosyrer

Country Status (34)

Country Link
US (2) US6773724B2 (fr)
EP (1) EP1365737B1 (fr)
JP (2) JP2004507463A (fr)
KR (1) KR100773658B1 (fr)
CN (1) CN1205176C (fr)
AR (1) AR030305A1 (fr)
AT (1) ATE293589T1 (fr)
AU (2) AU2001278471B2 (fr)
BR (1) BR0112538A (fr)
CA (1) CA2416288C (fr)
CR (1) CR6888A (fr)
CZ (1) CZ300337B6 (fr)
DE (2) DE10034802A1 (fr)
DK (1) DK1365737T3 (fr)
EC (1) ECSP034437A (fr)
ES (1) ES2241849T3 (fr)
GT (1) GT200100134A (fr)
HK (1) HK1061811A1 (fr)
HR (1) HRP20030108B1 (fr)
HU (1) HUP0302053A3 (fr)
IL (2) IL153873A0 (fr)
MX (1) MXPA03000510A (fr)
MY (1) MY134521A (fr)
NO (1) NO20030222L (fr)
PE (1) PE20020267A1 (fr)
PL (1) PL204593B1 (fr)
PT (1) PT1365737E (fr)
RS (1) RS50329B (fr)
SK (1) SK286162B6 (fr)
SV (1) SV2002000557A (fr)
TW (1) TWI299729B (fr)
UY (1) UY26841A1 (fr)
WO (1) WO2002005782A2 (fr)
ZA (1) ZA200300469B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
DE10202019A1 (de) * 2002-01-18 2003-07-24 Bayer Ag Stabile Salze von o-Acetylsalicylsäure mit basischen Aminosäuren II
US8142810B2 (en) 2002-05-30 2012-03-27 The Procter & Gamble Company Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
ATE442352T1 (de) * 2003-05-16 2009-09-15 Cephalon France Verfahren zur herstellung von modafinil
WO2006023844A2 (fr) * 2004-08-20 2006-03-02 Entremed, Inc. Compositions et procedes comportant des antagonistes de recepteur active par la proteinase
US20060166901A1 (en) * 2005-01-03 2006-07-27 Yu Ruey J Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
DE102005025283A1 (de) * 2005-06-02 2006-12-07 Bayer Healthcare Ag Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
DE102005049293A1 (de) * 2005-10-15 2007-04-26 Bayer Healthcare Ag Kombinationspräparate von Salzen oder o-Acetylsalicylsäure
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
EP2610242A1 (fr) 2006-07-09 2013-07-03 Techfields Biochem Co. Ltd Promédicaments hydrosolubles positivement chargés d'aspirine
US9371284B2 (en) 2007-06-04 2016-06-21 Techfields Pharma Co., Ltd. Pro-drugs of NSAIAS with very high skin and membranes penetration rates and their new medicinal uses
DE102008004386A1 (de) * 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
CN101314029B (zh) * 2008-06-18 2010-12-08 四川省农业科学院实验场 乙酰水杨酸肽及其制备方法
WO2010056919A2 (fr) * 2008-11-12 2010-05-20 Kyphia Pharmaceuticals, Inc. Promédicaments d'éflornithine, conjugués et sels, et procédés d'utilisation de ceux-ci
KR20230085223A (ko) 2008-12-04 2023-06-13 충시 위 고투과력을 가진 조성물 및 이의 적용
JP5706409B2 (ja) * 2009-06-25 2015-04-22 テトラ，エスイーアー 新規なサリチル酸塩
CN101633624B (zh) * 2009-08-04 2013-05-01 蚌埠丰原医药科技发展有限公司 改进的赖氨匹林的制备方法
FR2965261B1 (fr) * 2009-09-30 2012-10-26 Holis Technologies Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue par ce procede
FR2950625B1 (fr) * 2009-09-30 2016-12-02 Holis Tech Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue
FR2973370B1 (fr) * 2011-03-29 2013-05-03 Holis Technologies Procede a faible cout pour la preparation d'un acide o-acetylsalicyclique et d'un acide amine basique
CN102503845A (zh) * 2011-09-28 2012-06-20 广州普星药业有限公司 一种dl-赖氨酸阿司匹林盐的制备方法及其应用
KR102309973B1 (ko) 2012-05-16 2021-10-06 테크필즈 파마 코., 엘티디. 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물
CN102976962B (zh) * 2012-11-20 2015-02-04 南京工业大学 L-鸟氨酸阿司匹林复盐及其制备方法和应用
FR3021654B1 (fr) 2014-05-28 2016-06-24 Unither Pharmaceuticals Procede de preparation d'un sel d'acide acetylsalicylique et d'un acide amine basique
RU2764573C2 (ru) * 2016-12-23 2022-01-18 АспиЭйр ГмбХ Улучшенный синтез частиц ацетилсалицилата лизина ⋅ глицина
WO2018222583A1 (fr) * 2017-05-30 2018-12-06 Rho Pharmaceuticals, Llc Dépôt en flacon d'acide o-acétylsalicylique (aspirine) stable, stérile et cristallin
WO2019026992A1 (fr) * 2017-08-03 2019-02-07 参天製薬株式会社 Composition médicinale contenant de la chlorhexidine
CN113105326A (zh) * 2021-03-24 2021-07-13 海南卓华制药有限公司 赖氨匹林的制备方法及应用
CN114478287A (zh) * 2021-12-31 2022-05-13 蚌埠丰原医药科技发展有限公司 一种赖氨匹林晶型及制备方法和应用
WO2023131645A1 (fr) 2022-01-05 2023-07-13 Aspiair Gmbh Synthèse améliorée de particules d'acétylsalicylate de lysine · glycine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2115060A1 (en) * 1970-11-26 1972-07-07 Metabio Freeze-dried acetylsalicylates of lysine and arginine - easily prepd derivs of aspirin
ES388158A1 (es) * 1971-02-11 1974-03-16 Liade Sa Lab Procedimiento de obtencion de sales solubles del acido ace-til salicilico.
JPS4856815A (fr) * 1971-11-13 1973-08-09
JPS55127345A (en) * 1979-03-23 1980-10-02 Kyowa Hakko Kogyo Co Ltd Preparation of acetylsalicylic acid salt
JPS5610110A (en) * 1979-07-06 1981-02-02 Green Cross Corp:The Acetyl salicylate salt preparation for injection
JPS56113741A (en) * 1980-02-13 1981-09-07 Mitsui Toatsu Chem Inc Preparation of crystal of acetylsalicylic acid salt
JPS5721345A (en) * 1980-07-15 1982-02-04 Mitsui Toatsu Chem Inc Purification of acetylsalicylate salt
CS247688B1 (cs) * 1984-12-22 1987-01-15 Evzen Kasafirek Způsob výroby soli lysinu s kyselinou acetylsalicylovou
JPS632929A (ja) * 1986-06-20 1988-01-07 Kao Corp アセチルサリチル酸製剤
EP0499142A3 (en) * 1991-02-09 1993-05-05 Hoechst Aktiengesellschaft Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
ES2241849T3 (es) 2005-11-01
BR0112538A (pt) 2003-09-09
PL204593B1 (pl) 2010-01-29
CR6888A (es) 2004-10-28
DE50105985D1 (de) 2005-05-25
UY26841A1 (es) 2002-02-28
IL153873A0 (en) 2003-07-31
NO20030222D0 (no) 2003-01-16
JP2004507463A (ja) 2004-03-11
CN1205176C (zh) 2005-06-08
AR030305A1 (es) 2003-08-20
EP1365737B1 (fr) 2005-04-20
HRP20030108B1 (en) 2006-12-31
SV2002000557A (es) 2002-10-24
IL153873A (en) 2009-05-04
NO20030222L (no) 2003-01-16
SK672003A3 (en) 2003-06-03
US7449198B2 (en) 2008-11-11
RS50329B (sr) 2009-09-08
JP2012131824A (ja) 2012-07-12
CN1468209A (zh) 2004-01-14
CZ2003164A3 (cs) 2003-04-16
WO2002005782A3 (fr) 2003-10-02
PL365648A1 (en) 2005-01-10
AU2001278471B2 (en) 2004-07-22
ECSP034437A (es) 2003-03-31
EP1365737A2 (fr) 2003-12-03
AU7847101A (en) 2002-01-30
HUP0302053A3 (en) 2010-03-29
SK286162B6 (sk) 2008-04-07
CA2416288C (fr) 2009-12-22
HRP20030108A2 (en) 2005-02-28
WO2002005782A2 (fr) 2002-01-24
US6773724B2 (en) 2004-08-10
TWI299729B (en) 2008-08-11
CZ300337B6 (cs) 2009-04-22
PT1365737E (pt) 2005-08-31
MXPA03000510A (es) 2004-04-20
PE20020267A1 (es) 2002-06-08
KR20030019586A (ko) 2003-03-06
YU2003A (sh) 2006-08-17
US20020091108A1 (en) 2002-07-11
KR100773658B1 (ko) 2007-11-05
ZA200300469B (en) 2004-06-21
ATE293589T1 (de) 2005-05-15
HUP0302053A2 (hu) 2003-09-29
MY134521A (en) 2007-12-31
HK1061811A1 (en) 2004-10-08
CA2416288A1 (fr) 2003-01-15
US20050009791A1 (en) 2005-01-13
DE10034802A1 (de) 2002-01-31
GT200100134A (es) 2002-03-22

Similar Documents

Publication Publication Date Title
DK1365737T3 (da) Stabile salte af o-acetylsalicylsyre med basiske aminosyrer
CY2009011I2 (el) Αλατα προσθηκης οξεος παραγωγων υδροπυριδινης
DK1890994T3 (da) Stabilt aktivstofkompleks af salte af O-acetylsalicylsyre med basiske aminosyrer og glycin
DE60126611D1 (de) Ditosylatsalze von chinazolinverbindungen
NO20025823D0 (no) Beta-aminosyre nitril derivater
DK1163207T3 (da) Forbedret fremgangsmåde til fremstillingen af ikke-hygroskopiske salte af L(-)-carnitin
DK1449917T3 (da) Fremgangsmåde til L-aminosyrefremstilling under anvendelse af Escherichia
AU2001278471A1 (en) Stable salts of o-acetylsalicyclic with basic amino acids
NO20042172L (no) Insulinmolekyl med forlenget virkningstid
DK1328499T3 (da) Fremgangsmåde til fremstilling af carboxylsyresalte
EE200400023A (et) Uued sulfoonhappe derivaadid
ATE261431T1 (de) Kristalline form von (s)-2-ethoxy-3-4-(2-4- methansulfonyloxyphenyl-ethoxy)phenyl)propansäu e
DK1567482T3 (da) Fremgangsmåde til fremstilling af phenylmalonsyre-dinitriler
DE60217089D1 (de) Lipidsenkende biphenylcarbonsäureamide
NO20043404L (no) Stabile salter med o-acetylsalisylsyre inneholdende basiske aminosyrer II
DK1513806T3 (da) Sulfonsyresalte af sulfonsyrederivater
DK1648851T3 (da) Fremstilling af metalsalte af fedtsyrer med mellemlange kæder
DK1216253T3 (da) Fremgangsmåde til fremstilling af methylendiphosphonsyrer og salte deraf
DK1497290T3 (da) Fremgangsmåde til fremstilling af syresalte af gemifloxacin
PT1282598E (pt) Processo para o fabrico de sais de silfonil-benzoil-guanidinio
DK1272490T3 (da) Natriumsalt af et azoderivat af 5-aminosalicylsyre
DK1098871T3 (da) Phenylesterderivater af alfa-aminosyrer
DE50210903D1 (de) Herstellung von ammoniumsalzen aromatischer carbonsäuren
DK1242395T3 (da) Benzoesyreestere af oxazolidinoner med en hydroxyacetylpiperazinsubstituent
AR028272A1 (es) Inhibidores de la metaloproteasas de acido difluorobutirico